Option chain shows key data for Biote's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Biote.

Biote (NASDAQ:BTMD) Stock, Option Chain

Biote

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Meta Platforms Inc. (META)

News

Pre-Market Outlook

Markets

Trading Ideas

ANET

BTMD

CFLT

COYA

ETWO

LGMK

MSFT

NAOV

PAPL

PBPB

QCOM

RSVR

SGHC

SNDR

TRNR

VSTS

ZYBT

Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

Long Ideas

Penny Stocks

Small Cap

Insider Trades

CRYM

ERAS

HOWL

The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Over $4 Million Bet On Werewolf Therapeutics? Check Out These 4 Penny Stocks Insiders Are Buying

Movers

AMPE

ATXG

AVCT

BIAF

CEMI

CLBS

GFAI

GSUN

Hollsys Automation Technologies INTERNATIONAL

HOLI

ISPO

KPTI

LULU

NBEV

NINE

PIXY

PXMD

SGML

SHIP

SHPH

TAOP

VRAX

RVPH

Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket

Biote Corp

Press Releases

Biote Reports Second Quarter 2024 Financial Results

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

Biote Reports Third Quarter 2024 Financial Results

AccessHope Expands Executive Leadership Team Amid Rapid Growth and Upcoming Market Expansion

Biote Announces CEO Retirement and Succession Plan

Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call

Biote Reports Fourth Quarter and Full Year 2024 Financial Results

Biote Announces Purchase of Shares by Directors and CEO

Biote Schedules First Quarter 2025 Financial Results Release and Conference Call

Biote Reports First Quarter 2025 Financial Results

HOLX

MYGN

PODD

REXR

Aardvark Therapeutics, Inc. - Common Stock

Aardvark Therapeutics

Aclaris Therapeutics, Inc. - Common Stock

Aclaris Therapeutics

ALT5 Sigma

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics

Atea Pharmaceuticals, Inc. - common stock

Atea Pharmaceuticals

Bioage Labs

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Contineum Therapeutics, Inc. - Common stock

Contineum Therapeutics

Journey Medical Corporation - Common Stock

Journey Medical

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics

Nektar Therapeutics

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics

NeOnc Technologies Holdings, Inc. - Common Stock

NeOnc Technologies

Omeros

OptiNose

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals

Pliant Therapeutics

Cassava Sciences

scPharmaceuticals

Telomir Pharmaceuticals, Inc. - Common Stock

Telomir Pharmaceuticals

Third Harmonic Bio

Universe Pharmaceuticals Inc - Ordinary Shares

Universe Pharmaceuticals

Veru

Ventyx Biosciences

Craig-Hallum

Roth MKM

B. Riley Securities

Jefferies

Truist Securities

Comments

Biote

Biote (BTMD) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell